Arch Pathol Lab Med 2010, 134:90–94.PubMed 13. Koch A, Poirier F, Jacob R, Delacour D: Galectin-3, a novel centrosome-associated protein, required for epithelial morphogenesis. Mol Biol Cell 2010, 21:219–231.PubMedCrossRef 14. Madej A, Puzianowska-Kuznicka M, Tanski Z, Nauman J, Nauman A: Vitamin D receptor binding to DNA is altered without the change in its expression in human renal clear cell cancer. Nephron Exp Nephrol 2003, 93:e150-e157.PubMedCrossRef 15. Young AN, Amin MB, Moreno CS, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS: Expression profiling of renal epithelial neoplasms-A method for tumor classification and discovery of
diagnostic molecular markers. American Journal of Pathology 2001, 158:1639–1651.PubMedCrossRef 16. Oberling C, Riviere M, Haguenau F: Ultrastructure
of the Clear Cells in Renal Carcinomas and Its Importance for the Demonstration SIS3 of Their Renal Origin. Bortezomib molecular weight Nature 1960, 186:402–403.PubMedCrossRef 17. Shimazui T, Bringuier PP, van BH, Ruijter E, Akaza H, Debruyne FM, Oosterwijk E, Schalken JA: Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinoma. Int J Cancer 1997, 74:523–528.PubMedCrossRef 18. Vila MR, Nicolas A, Morote J, de I, Meseguer A: Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction. Cancer 2000, 89:152–164.PubMedCrossRef 19. Kim SJ, Choi Chlormezanone IJ, Cheong TC, Lee SJ, Lotan R, Park SH, Chun KH: Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 2010, 138:1035–1045.PubMedCrossRef 20. Kobayashi T, Shimura T, Yajima T, Kubo N, Araki K, Tsutsumi S, Sotrastaurin Suzuki H, Kuwano H, Raz A: Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of beta-catenin. Int J Cancer 2011. 21. Takata K, Matsuzaki T, Tajika Y, Ablimit A, Hasegawa T: Localization and trafficking of aquaporin 2 in the kidney. Histochem Cell Biol 2008, 130:197–209.PubMedCrossRef
22. Robine S, Huet C, Moll R, Sahuquillo-Merino C, Coudrier E, Zweibaum A, Louvard D: Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells? Proc Natl Acad Sci USA 1985, 82:8488–8492.PubMedCrossRef 23. Eidelman S, Damsky CH, Wheelock MJ, Damjanov I: Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol 1989, 135:101–110.PubMed 24. Liu FT, Rabinovich GA: Galectins as modulators of tumour progression. Nature Reviews Cancer 2005, 5:29–41.PubMedCrossRef 25. Katagiri A, Watanabe R, Tomita Y: E-cadherin expression in renal cell cancer and its significance in metastasis and survival. Br J Cancer 1995, 71:376–379.PubMedCrossRef 26.